US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 36.990
  • +0.850+2.35%
Close Nov 27 16:00 ET
  • 36.990
  • 0.0000.00%
Post 16:02 ET
2.04BMarket Cap34.67P/E (TTM)

Supernus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
14.17%175.69M
24.17%168.33M
-6.58%143.64M
-8.95%607.52M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
0.82%153.76M
15.09%667.24M
5.20%167.33M
Operating revenue
14.17%175.69M
24.17%168.33M
-6.58%143.64M
-8.95%607.52M
-1.80%164.31M
-13.24%153.88M
-20.28%135.56M
0.82%153.76M
15.09%667.24M
5.20%167.33M
Cost of revenue
-10.30%17.58M
-15.05%17.92M
-30.48%16.31M
-3.95%83.78M
-14.49%19.63M
-24.26%19.6M
3.10%21.09M
30.83%23.46M
16.20%87.22M
35.07%22.95M
Gross profit
17.74%158.11M
31.39%150.41M
-2.28%127.34M
-9.70%523.74M
0.22%144.69M
-11.35%134.28M
-23.48%114.47M
-3.17%130.3M
14.92%580.02M
1.63%144.37M
Operating expense
-6.57%118.28M
0.71%132.2M
3.79%131.58M
-4.50%510.34M
11.79%125.7M
-16.99%126.6M
-4.54%131.27M
-3.92%126.78M
25.68%534.4M
-16.61%112.44M
Selling and administrative expenses
-15.66%69.75M
-1.01%85.9M
1.07%86.52M
-10.83%336.36M
9.88%81.28M
-26.37%82.7M
-13.63%86.78M
-5.37%85.6M
23.78%377.22M
-27.29%73.97M
-Selling and marketing expense
-4.33%54.33M
-1.82%58.8M
4.08%59.57M
-14.42%229.19M
15.18%55.28M
-33.74%56.79M
-18.60%59.89M
-5.43%57.23M
--267.79M
--47.99M
-General and administrative expense
-40.48%15.42M
0.79%27.1M
-5.00%26.95M
-2.06%107.18M
0.09%26.01M
-2.61%25.92M
-0.03%26.89M
-5.27%28.37M
--109.43M
--25.98M
Research and development costs
28.17%29.04M
7.40%26.18M
17.53%24.93M
22.86%91.59M
31.35%23.35M
15.86%22.66M
48.79%24.38M
1.79%21.21M
-17.59%74.55M
-15.68%17.77M
Depreciation amortization depletion
-8.26%19.49M
0.00%20.11M
0.86%20.14M
-0.30%82.39M
1.79%21.07M
2.90%21.24M
-2.60%20.11M
-3.28%19.97M
175.53%82.63M
72.12%20.7M
-Depreciation and amortization
-8.26%19.49M
0.00%20.11M
0.86%20.14M
-0.30%82.39M
1.79%21.07M
2.90%21.24M
-2.60%20.11M
-3.28%19.97M
175.53%82.63M
72.12%20.7M
Operating profit
418.47%39.83M
208.44%18.21M
-220.37%-4.25M
-70.62%13.4M
-40.53%18.99M
840.79%7.68M
-238.94%-16.8M
34.08%3.53M
-42.62%45.61M
342.37%31.93M
Net non-operating interest income expense
134.04%4.1M
711.52%3.73M
-11.59%3.4M
-45.02%8.04M
146.40%1.99M
62.28%1.75M
2,190.91%460K
-69.89%3.84M
213.73%14.62M
119.92%806K
Non-operating interest income
134.04%4.1M
172.48%3.73M
-36.48%3.4M
-51.81%10.45M
-17.25%1.99M
-37.53%1.75M
-23.38%1.37M
-63.63%5.35M
105.21%21.69M
27.19%2.4M
Non-operating interest expense
--0
--0
--0
-65.84%2.42M
--0
--0
-49.72%910K
-22.50%1.51M
-69.82%7.07M
-73.14%1.59M
Other net income (expense)
122.81%1.02M
651.27%4.36M
-33.52%1.1M
-3,761.18%-18.67M
-931.32%-19.99M
193.83%456K
-6.33%-790K
347.67%1.65M
-92.19%510K
314.64%2.4M
Special income (charges)
122.81%1.02M
651.27%4.36M
-33.52%1.1M
-3,761.18%-18.67M
-931.32%-19.99M
193.83%456K
-6.33%-790K
347.67%1.65M
-92.19%510K
314.64%2.4M
-Less：Restructuring and merger&acquisition
-122.81%-1.02M
-651.27%-4.36M
33.52%-1.1M
-197.45%-1.52M
91.51%-204K
-193.83%-456K
6.33%790K
-347.67%-1.65M
92.19%-510K
-314.64%-2.4M
-Less:Impairment of capital assets
----
----
----
--20.19M
----
----
----
----
--0
----
Income before tax
354.47%44.94M
253.57%26.3M
-97.31%243K
-95.44%2.77M
-97.18%990K
2,327.25%9.89M
-251.25%-17.13M
-38.76%9.02M
-16.99%60.74M
1,613.31%35.14M
Income tax
-75.08%6.45M
139.19%6.39M
101.50%119K
4,440.63%1.45M
-101.92%-185K
1,279.43%25.87M
-571.12%-16.3M
27.19%-7.93M
-99.84%32K
2,570.33%9.66M
Net income
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
Net income continuous Operations
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
Minority interest income
Net income attributable to the parent company
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
340.97%38.5M
2,496.63%19.92M
-99.27%124K
-97.83%1.32M
-95.39%1.18M
-1,013.44%-15.98M
-110.57%-831K
-33.84%16.95M
13.64%60.71M
943.45%25.48M
Basic earnings per share
341.38%0.7
1,900.00%0.36
-99.27%0.0023
-98.23%0.02
-96.30%0.0174
-1,066.67%-0.29
-113.33%-0.02
-35.42%0.31
11.88%1.13
840.00%0.47
Diluted earnings per share
337.93%0.69
1,900.00%0.36
-99.23%0.0022
-98.08%0.02
-95.95%0.0174
-1,066.67%-0.29
-114.29%-0.02
-32.56%0.29
6.12%1.04
975.00%0.43
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 14.17%175.69M24.17%168.33M-6.58%143.64M-8.95%607.52M-1.80%164.31M-13.24%153.88M-20.28%135.56M0.82%153.76M15.09%667.24M5.20%167.33M
Operating revenue 14.17%175.69M24.17%168.33M-6.58%143.64M-8.95%607.52M-1.80%164.31M-13.24%153.88M-20.28%135.56M0.82%153.76M15.09%667.24M5.20%167.33M
Cost of revenue -10.30%17.58M-15.05%17.92M-30.48%16.31M-3.95%83.78M-14.49%19.63M-24.26%19.6M3.10%21.09M30.83%23.46M16.20%87.22M35.07%22.95M
Gross profit 17.74%158.11M31.39%150.41M-2.28%127.34M-9.70%523.74M0.22%144.69M-11.35%134.28M-23.48%114.47M-3.17%130.3M14.92%580.02M1.63%144.37M
Operating expense -6.57%118.28M0.71%132.2M3.79%131.58M-4.50%510.34M11.79%125.7M-16.99%126.6M-4.54%131.27M-3.92%126.78M25.68%534.4M-16.61%112.44M
Selling and administrative expenses -15.66%69.75M-1.01%85.9M1.07%86.52M-10.83%336.36M9.88%81.28M-26.37%82.7M-13.63%86.78M-5.37%85.6M23.78%377.22M-27.29%73.97M
-Selling and marketing expense -4.33%54.33M-1.82%58.8M4.08%59.57M-14.42%229.19M15.18%55.28M-33.74%56.79M-18.60%59.89M-5.43%57.23M--267.79M--47.99M
-General and administrative expense -40.48%15.42M0.79%27.1M-5.00%26.95M-2.06%107.18M0.09%26.01M-2.61%25.92M-0.03%26.89M-5.27%28.37M--109.43M--25.98M
Research and development costs 28.17%29.04M7.40%26.18M17.53%24.93M22.86%91.59M31.35%23.35M15.86%22.66M48.79%24.38M1.79%21.21M-17.59%74.55M-15.68%17.77M
Depreciation amortization depletion -8.26%19.49M0.00%20.11M0.86%20.14M-0.30%82.39M1.79%21.07M2.90%21.24M-2.60%20.11M-3.28%19.97M175.53%82.63M72.12%20.7M
-Depreciation and amortization -8.26%19.49M0.00%20.11M0.86%20.14M-0.30%82.39M1.79%21.07M2.90%21.24M-2.60%20.11M-3.28%19.97M175.53%82.63M72.12%20.7M
Operating profit 418.47%39.83M208.44%18.21M-220.37%-4.25M-70.62%13.4M-40.53%18.99M840.79%7.68M-238.94%-16.8M34.08%3.53M-42.62%45.61M342.37%31.93M
Net non-operating interest income expense 134.04%4.1M711.52%3.73M-11.59%3.4M-45.02%8.04M146.40%1.99M62.28%1.75M2,190.91%460K-69.89%3.84M213.73%14.62M119.92%806K
Non-operating interest income 134.04%4.1M172.48%3.73M-36.48%3.4M-51.81%10.45M-17.25%1.99M-37.53%1.75M-23.38%1.37M-63.63%5.35M105.21%21.69M27.19%2.4M
Non-operating interest expense --0--0--0-65.84%2.42M--0--0-49.72%910K-22.50%1.51M-69.82%7.07M-73.14%1.59M
Other net income (expense) 122.81%1.02M651.27%4.36M-33.52%1.1M-3,761.18%-18.67M-931.32%-19.99M193.83%456K-6.33%-790K347.67%1.65M-92.19%510K314.64%2.4M
Special income (charges) 122.81%1.02M651.27%4.36M-33.52%1.1M-3,761.18%-18.67M-931.32%-19.99M193.83%456K-6.33%-790K347.67%1.65M-92.19%510K314.64%2.4M
-Less：Restructuring and merger&acquisition -122.81%-1.02M-651.27%-4.36M33.52%-1.1M-197.45%-1.52M91.51%-204K-193.83%-456K6.33%790K-347.67%-1.65M92.19%-510K-314.64%-2.4M
-Less:Impairment of capital assets --------------20.19M------------------0----
Income before tax 354.47%44.94M253.57%26.3M-97.31%243K-95.44%2.77M-97.18%990K2,327.25%9.89M-251.25%-17.13M-38.76%9.02M-16.99%60.74M1,613.31%35.14M
Income tax -75.08%6.45M139.19%6.39M101.50%119K4,440.63%1.45M-101.92%-185K1,279.43%25.87M-571.12%-16.3M27.19%-7.93M-99.84%32K2,570.33%9.66M
Net income 340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M
Net income continuous Operations 340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M
Minority interest income
Net income attributable to the parent company 340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 340.97%38.5M2,496.63%19.92M-99.27%124K-97.83%1.32M-95.39%1.18M-1,013.44%-15.98M-110.57%-831K-33.84%16.95M13.64%60.71M943.45%25.48M
Basic earnings per share 341.38%0.71,900.00%0.36-99.27%0.0023-98.23%0.02-96.30%0.0174-1,066.67%-0.29-113.33%-0.02-35.42%0.3111.88%1.13840.00%0.47
Diluted earnings per share 337.93%0.691,900.00%0.36-99.23%0.0022-98.08%0.02-95.95%0.0174-1,066.67%-0.29-114.29%-0.02-32.56%0.296.12%1.04975.00%0.43
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data